"A radioimmunoconjugate comprised of the chimeric monoclonal antibody G250 conjugated with the positron emitter iodine I 124. The antibody moiety of iodine I 124 chimeric monoclonal antibody G250 may bind to renal cell carcinoma (RCC) cells that express the RCC-associated antigen G250, allowing detection of tumor-localized iodine I 124 with positron emission tomography (PET). G250 is a cell surface tumor-associated antigen (TAA) that is found in the majority of renal cell carcinomas.NCI" . "C53407"^^ . . "465493"^^ . "Iodine_I_124_Chimeric_Monoclonal_Antibody_cG250"^^ . "124I-cG250ABNCI" . "FDA"^^ . "465493"^^ . "Iodine I-124 Girentuximab"^^ . "124IcG250CNNCI" . "P0I0FT82VK"^^ . "Iodine I-124 Girentuximab"^^ . "Iodine I-124 GirentuximabPTNCI" . "RedectaneBRNCI" . . "GIRENTUXIMAB I-124PTFDAP0I0FT82VK" . "Iodine I 124 Chimeric Monoclonal Antibody G250SYNCI" . . "I 124 MoAb cG250ABNCI" . "Immunologic Factor"^^ . "CL383142"^^ . "Amino Acid, Peptide, or Protein"^^ . "1011710-99-8"^^ .